Rollover Study in Participants With Metastatic Solid Tumors Benefiting From Therapy With Sacituzumab Govitecan-hziy
Completed · Phase 4
Conditions studied: Metastatic Solid Tumors
In brief
The goal of this clinical study is to learn more about the study drug, sacituzumab govitecan-hziy (SG), and how safe it is in participants with metastatic cancer (cancer that has spread).
Key facts
- Study ID
- NCT04319198
- Run by
- Gilead Sciences
- People needed
- 25
- Starts
- 2020-08-04
- Expected to finish
- 2024-10-18
- Last updated by the study team
- 2025-09-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California San Francisco — San Francisco, California, United States
- Rocky Mountain Cancer Center — Aurora, Colorado, United States
- Christiana Care Health Services, Christiana Hospital — Newark, Delaware, United States
- Florida Cancer Specialists & Research Institute — Fort Myers, Florida, United States
- Baptist Health - Miami Cancer Institute — Miami, Florida, United States
- Illinois Cancer Specialists — Arlington Heights, Illinois, United States
- University of Chicago — Chicago, Illinois, United States
- University of MD Greenebaum Comprehensive Cancer Center — Baltimore, Maryland, United States
- Massachusetts General Hospital — Boston, Massachusetts, United States
- Dana Farber Cancer Institute — Boston, Massachusetts, United States
- New York Cancer & Blood Specialists - Setauket Medical Oncology — Port Jefferson, New York, United States
- UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania, United States
- Next Oncology — Austin, Texas, United States
- Oncology Consultants,P.A. — Houston, Texas, United States
- The University of Texas M.D. Anderson Cancer Center — Houston, Texas, United States
- NEXT Oncology — San Antonio, Texas, United States
- Institut Jules Bordet — Brussels, Belgium
- CHU UCL NAMUR - Sainte Elisabeth — Namur, Belgium
- Institut Bergonie — Bordeaux, France
- Centre Leon Berard — Lyon, France
- Institut Claudius Regaud — Toulouse, France
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.